TERRE HAUTE, Ind. (WTWO/WAWV) — Chief executive officer and co-founder of EpiBone, the world’s first company to grow living human bone for skeleton reconstruction, Nina Tandon, PhD, will be delivering a special address at Rose-Hulman Institute of Technology.
Under Dr. Tandon’s leadership, EpiBone has received approval from the Federal Drug Administration for its stem cell technology. This technology promises to simplify surgery procedures, improve bone formation and shorten patient recovery time.
Dr. Tandon’s groundbreaking work in biomedical engineering has earned recognition as one of the Most Creative in Business by Fast Company, an Innovative Fellow by WIRED and a World Economic Forum Tech Pioneer.
“Dr. Tandon is leading us into an exciting world where we could possibly create our own futures, using our own cells for our health and healing purposes,” said Rose-Hulman Associate Professor of Chemical Engineering Irene Reizman, PhD, creator of the Rose Research Fellows program, which is being supported by her term as the Alfred R. Schmidt Endowed Chair for Excellence in Teaching. “This will be an excellent opportunity for our students and others interested in science and scientific research from throughout the Wabash Valley to get insight about innovative biotechnology research from a pioneer in the field of cell biology.”
The event, which is free and open to the public, will take place at the Hatfield Hall Theater on Thursday, January 30, at 5:30 p.m.
No advanced tickets are necessary, and seating will be on a first-come, first-served basis.
